Bio-Thera Solutions Ltd (688177) - Total Liabilities

Latest as of March 2026: CN¥2.16 Billion CNY ≈ $316.22 Million USD

Based on the latest financial reports, Bio-Thera Solutions Ltd (688177) has total liabilities worth CN¥2.16 Billion CNY (≈ $316.22 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Bio-Thera Solutions Ltd - Total Liabilities Trend (2016–2025)

This chart illustrates how Bio-Thera Solutions Ltd's total liabilities have evolved over time, based on quarterly financial data. See working capital to net assets of Bio-Thera Solutions Ltd to evaluate short-term liquidity relative to the company's equity base.

Bio-Thera Solutions Ltd Competitors by Total Liabilities

The table below lists competitors of Bio-Thera Solutions Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Sunflower Pharmaceuticals Group Co Ltd SHE:002737	China	CN¥1.25 Billion
Bangkok Chain Hospital Public Company Limited BK:BCH-R	Thailand	฿3.43 Billion
Zhejiang Guyuelongshan Shaoxing Wine Co Ltd SHG:600059	China	CN¥757.86 Million
Tianjin Ringpu Bio Tech SHE:300119	China	CN¥2.53 Billion
Jiangsu Yinhe Electronics Co Ltd SHE:002519	China	CN¥1.04 Billion
Shunfa Hengye Corp SHE:000631	China	CN¥1.72 Billion
Hbt Financial Inc NASDAQ:HBT	USA	$6.03 Billion
Inner Mongolia ERDOS Resources Co Ltd B SHG:900936	China	$19.27 Billion

Liability Composition Analysis (2016–2025)

This chart breaks down Bio-Thera Solutions Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 688177 market cap.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.67	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	9.64	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.91	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Bio-Thera Solutions Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Bio-Thera Solutions Ltd (2016–2025)

The table below shows the annual total liabilities of Bio-Thera Solutions Ltd from 2016 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥1.91 Billion ≈ $279.68 Million	+27.64%
2024-12-31	CN¥1.50 Billion ≈ $219.12 Million	+39.38%
2023-12-31	CN¥1.07 Billion ≈ $157.22 Million	+87.67%
2022-12-31	CN¥572.48 Million ≈ $83.77 Million	+7.96%
2021-12-31	CN¥530.27 Million ≈ $77.60 Million	+36.82%
2020-12-31	CN¥387.56 Million ≈ $56.71 Million	+1.01%
2019-12-31	CN¥383.68 Million ≈ $56.15 Million	+74.85%
2018-12-31	CN¥219.44 Million ≈ $32.11 Million	-19.14%
2017-12-31	CN¥271.39 Million ≈ $39.71 Million	+56.10%
2016-12-31	CN¥173.86 Million ≈ $25.44 Million	--

About Bio-Thera Solutions Ltd

SHG:688177 China Biotechnology

Market Cap

$1.03 Billion

CN¥7.06 Billion CNY

Market Cap Rank

#8927 Global

#2249 in China

Share Price

CN¥17.06

Change (1 day)

+4.22%

52-Week Range

CN¥16.37 - CN¥34.72

All Time High

CN¥71.90